GLP-1 receptor agonists and SGLT-2 inhibitors in patients with versus without cardiovascular disease: A systematic review, meta-analysis, and trial sequential analysis
Hayflick L
Dosing appears to play a role some trials have shown antioxidant effects with 800mg/day, while others suggest stronger responses at 1,2002,400mg/day, particularly for lowering oxidative stress biomarkers in patients with multiple sclerosis.3 28 Keep in mind, though: while higher doses (typically 1,2002,400mg per day) may offer stronger antioxidant effects, they also come with a greater chance of side effects like upset stomach or dizziness
Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species
GLP-1 Pharmacology Glucagon-like peptide 1 agonists simulate the action of incretin, which is a hormone produced by the small intestines, that bind to the GLP-1 receptor
Glutathione is also a constituent in the regulation of protein and gene expression, exchange reactions including thiol to disulfide ratios involve glutathione.[4] Glutathione can exist intracellularly in either an oxidized (glutathione disulfide) or reduced (glutathione) molecular state
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
